Article

Predictive Effect of Spatial Protein Signature in Advanced Non-small Cell Lung Cancer Patients Treated with Bispecific Antibody (KN046) Immunotherapy

2022-04-15

Abstract excerpt

<h4>Background: </h4> Immunotherapy, targeting programmed death ligand-1 (PD-L1) and cytotoxic T lymphocyte-associated antigen-4, has shown significant antitumor activity and favourable safety profile in patients with advanced non-small cell lung cancer (NSCLC), while predictive biomarkers remain largely unknown. Here, we investigated the predictive effect of spatial protein expression signature of KN046, a bispec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 80e1561c-4f17-5fd3-99b7-8228f156bd3d
DOI: 10.21203/rs.3.rs-1553755/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predictive Effect of Spatial Protein Signature in Advanced Non-small Cell Lung Cancer Patients Treated with Bispecific Antibody (KN046) ImmunotherapyDOI 10.21203/rs.3.rs-1553755/v1Read

High-Plex and High-throughput Digital Spatial Profiling of non-small-cell lung cancer (NSCLC)Semantic proximity Read

Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapySemantic proximity Read

Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 ExpressionSemantic proximity Read

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer.Semantic proximity Read

Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Models for Non-Small Cell Lung CancerSemantic proximity Read

Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancerSemantic proximity Read

From Pixels to Insights: Unveiling Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer using Multiplexed Tissue ImagingSemantic proximity Read

Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy responseSemantic proximity Read

Predictive value of the biomarker of peripheral blood of NSCLC patients responding to anti-PD-1 treatmentSemantic proximity Read

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer.Semantic proximity Read

Computational biomarker predicts lung ICI response via deep learning-driven hierarchical spatial modelling from H&ESemantic proximity Read

Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerSemantic proximity Read